|
Smith Byrne K, Appleby PN, Key TJ, Holmes MV, Fensom GK, Agudo A, Ardanaz E, Boeing H, Bueno-de-Mesquita HB, Chirlaque MD, Kaaks R, Larranaga N, Palli D, Perez-Cornago A, Quiros JR, Ricceri F, Sanchez MJ, Tagliabue G, Tsilidis KK, Tumino R, Fortner RT, Ferrari P; PRACTICAL Consortium; Riboli E, Lilja H, Travis RC. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition. Ann Oncol. 2019 Jun 1;30(6):983-989. doi: 10.1093/annonc/mdz121. PubMed PMID: 31089709; PubMed Central PMCID: PMC6594452.
AÑO: 2019; IF: 18.274
|
31089709
|
Navarro-Mateu F, Rubio-Aparicio M, Cayuela P, Alvarez FJ, Roca-Vega A, Chirlaque MD, Cayuela ML, Husky M, Martinez S, Sanchez-Meca J. The association of telomere length with substance use disorders: systematic review and meta-analysis protocol. Syst Rev. 2019 Dec 1;8(1):298. doi: 10.1186/s13643-019-1199-x. PubMed PMID: 31787100; PubMed Central PMCID: PMC6886210.
AÑO: 2019
|
|
Ward HA, Murphy N, Weiderpass E, Leitzmann MF, Aglago E, Gunter MJ, Freisling H, Jenab M, Boutron-Ruault MC, Severi G, Carbonnel F, Kuhn T, Kaaks R, Boeing H, Tjonneland A, Olsen A, Overvad K, Merino S, Zamora-Ros R, Rodriguez-Barranco M, Dorronsoro M, Chirlaque MD, Barricarte A, Perez-Cornago A, Trichopoulou A, Bamia C, Lagiou P, Masala G, Grioni S, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita B, Vermeulen R, Van Gils C, Nystrom H, Rutegard M, Aune D, Riboli E, Cross AJ. Gallstones and incident colorectal cancer in a large pan-European cohort study. Int J Cancer. 2019 Sep 15;145(6):1510-1516. doi: 10.1002/ijc.32090. Epub 2019 Jan 11. PubMed PMID: 30585640.
AÑO: 2019; IF: 5.145
|
|
Andreu-Reinon ME, Gavrila D, Chirlaque MD, Colorado-Yohar SM, Amiano P, Ardanaz E, Navarro-Mateu F, Navarro C, Huerta JM. Ascertainment of Dementia Cases in the Spanish European Prospective Investigation into Cancer and Nutrition-Murcia Cohort. Neuroepidemiology. 2019;52(1-2):63-73. doi: 10.1159/000493209. Epub 2018 Nov 26. PubMed PMID: 30476922.
AÑO: 2019; IF: 2.186
|
|
Navarro-Mateu F, Quesada MP, Escamez T, Alcaraz MJ, Seiquer de la Pena C, Salmeron D, Huerta JM, Vilagut G, Chirlaque MD, Navarro C, Husky M, Kessler RC, Alonso J, Martinez S. Childhood adversities and 5-HTTLPR polymorphism as risk factors of substance use disorders: retrospective case-control study in Murcia (Spain). BMJ Open. 2019 Sep 4;9(9):e030328. doi: 10.1136/bmjopen-2019-030328. PubMed PMID: 31488488; PubMed Central PMCID: PMC6731914.
AÑO: 2019; IF: 2.496
|